DrugAgent: Revolutionizing Drug-Target Interaction with AI
DrugAgent uses AI to integrate diverse drug-target interaction data. Evaluated on kinase and antagonist benchmarks, it shows promise for evidence-grounded assessments.
Read the full articleYou might also wanna read
MCP and Pharma: How AI Agents Connect to Drug Discovery, Clinical Trials, Genomics, Chemical Databases, Protein Structure, FDA Regulatory Data, and Life Sciences Platforms
A comprehensive guide to MCP integrations for pharmaceuticals, biotechnology, and life sciences — covering drug discovery tools (RDKit, mole
AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design
Featured content
drugtargetreview.com·5mo agoHow Will AI Transform the Future of Drug Discovery? AI Brings New Hope for Drug Development
Explore how AI is revolutionizing drug discovery, reducing costs, and accelerating treatment development for complex diseases like idiopathi
Aureka offers open-source AI module for drug discovery
Aureka offers open-source AI module for drug discovery Phil.Taylor Wed, 08/07/2026 - 13:18
AI Drug Discovery Stalled by Lack of Trustworthy Biological Data
To unleash the potential of AI in life sciences and drug discovery, biological datasets must be authenticated, validated, and supported by s
the-scientist.com·17d agoAI Drug Discovery Stalled by Lack of Trustworthy Biological Data
To unleash the potential of AI in life sciences and drug discovery, biological datasets must be authenticated, validated, and supported by s
The Scientist·17d ago
Uneven Frontiers
How AI will transform biopharma—and why the sequence of change matters
Comments
Sign in to join the conversation.
No comments yet. Be the first.